Assessment of Magnesium sulphate and ondansetronon on propofol 2% injection pai
Not Applicable
- Conditions
- Propofol injection pain.Other and unspecified general anaesthetics
- Registration Number
- IRCT2013092613182N3
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Inclusion:patients undergoing vitrectomy operation using general anesthesia with American Society of Anesthesiologists physical status I and II.
Exclusion: known sensitivity to propofol or ondansetron; receiving analgesic or sedative medication in the last 24 hours; presence of infection on the dorsum of the left hand; indications for rapid sequence intubation; presence of cardiac conduction defects; epilepsy; and use of antiarrhythmic medications, thin dorsal veins, renal and liver diseases, neuro-muscular diseases, pregnant women, and uncooperative patients were excluded
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Propofol injection pain. Timepoint: 5, 10, 20 and 25 seconds after trial intervention. Method of measurement: with 4 points scale.
- Secondary Outcome Measures
Name Time Method